FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102143 [Registered on: 27/01/2026] Trial Registered Prospectively
Last Modified On: 23/01/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A Pilot Study To Evaluate The Clinical Efficacy Of Siddha Varmam Therapy In Autism Spectrum Disorder 
Scientific Title of Study   A Pilot Study to Evalutae the Therapeutic Efficacy of Siddha Varmam therapy in Autism Spectrum Disorder 
Trial Acronym  Siddha varmam therapy in Autism Spectrum Disorder 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR R Revathy 
Designation  Assistant Medical officer Siddha 
Affiliation  Arignar Anna Government Hospital of Hospital of Indian Medicine, Arumbakkam, Chennai 106 
Address  Department Of Varmam Arignar Anna Government Hospital of Indian Medicine Arumbakkam chennai
Arignar Anna Government Hospital of indian medicine Arumbakkam Chennai 600106
Chennai
TAMIL NADU
600106
India 
Phone  9840512810  
Fax    
Email  drrevathymd@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr TR Siddique ali 
Designation  Professor 
Affiliation  Government Siddha Medical College 
Address  Post Graduate department of Varmam Maruthuvam Government Siddha Medical College arumbakkam
Director Incharge Arignar Anna Government Hospital Of Indian Medicine Arumbakkam Chennai 600106
Chennai
TAMIL NADU
600106
India 
Phone  09962019900  
Fax    
Email  tkrsiddique@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr TR Siddique ali 
Designation  Professor 
Affiliation  Government Siddha Medical College 
Address  Post Graduate department of Varmam Maruthuvam Government Siddha Medical College Arumbakkam Chennai
Director Incharge Arignar Anna Government Hospital of Indian Medicine Arumbakkam Chennai 600106
Chennai
TAMIL NADU
600106
India 
Phone  09962019900  
Fax    
Email  tkrsiddique@gmail.com  
 
Source of Monetary or Material Support  
Dr R Revathy 
 
Primary Sponsor  
Name  DrRRevathy 
Address  Arignar Anna Government Hospital of Indian Medicine Arumbakkam Chennai 600106 Chennai 600106 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR R Revathy  Arignar Anna Government Hospital of Indian Medicine  Arignar Anna Government Hospital of Indian Medicine Arumbakkam Chennai 600106
Chennai
TAMIL NADU 
09840512810

drrevathymd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F59||Unspecified behavioral syndromes associated with physiological disturbances and physical factors,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NOT APPLICABLE  NOT APPLICABLE 
Intervention  Siddha Varmam Therapy  All Patients Satisfying Inclusion Criteria Will be Given Varmam Therapy Weekly Once For 8 Weeks 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Age 2 TO 12 Years
Sex Both male and Female children
Children having Lack of eye contact
Lack of Response
Repititive or restricted Behaviour
Unaware of natural urges
Acquired speech or lost it
Unusual sensitive to sensory stimuli
 
 
ExclusionCriteria 
Details  Children above 12 years and below 2 years
Severe and Recurrent seizures
ADHD
Cerebral palsy
Infantile hemiplegia
Congenital anamolies
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Outcome is assessed by reduction of the clinical symptoms  Outcome is assessed by reduction scores in Scale of Indian Scale of Assesment of Autism measured weekly once for 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
outcome will be assesed by reduction of clinical symptoms  outcome is mainly assesed using scores from Indian Scale for assesment of Autism before & after treatment in the basis of weekly 1 time for 8 weeks
 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  04/02/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study protocol is designed to systematically evaluate the thereupeutic efficacy of siddha varmam therapy in the management of Autism spectrum disorder by integreating traditional siddha principles with standardized clinical assesments 
Close